Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2026)

Bicycle Therapeutics (BCYC) reported Other Non-Current Assets of $13.0 million for Q1 2026, up 5.11% on a YoY basis from $12.4 million in Q1 2025, and up 1.46% quarter-over-quarter from $12.8 million in Q4 2025.

Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2026) Analysis & Trends

Bicycle Therapeutics has reported Other Non-Current Assets for 9 years, with the latest figure at $13.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 5.11% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $13.0 million (up 5.11% YoY), and the FY2025 full-year result was $12.8 million, up 15.63% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $13.0 million, up from $12.8 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $13.8 million in Q2 2025, with the low at $4.2 million in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $9.3 million across 5 years, with a median of $9.9 million in 2024.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 151.69% — and 2024, when it sank 45.83%.
  • Bicycle Therapeutics' Other Non-Current Assets stood at $8.5 million in 2022, then tumbled by 31.52% to $5.8 million in 2023, then jumped by 91.19% to $11.1 million in 2024, then increased by 15.63% to $12.8 million in 2025, then increased by 1.46% to $13.0 million in 2026.
  • The last three Other Non-Current Assets figures came in at $13.0 million (Q1 2026), $12.8 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Bicycle Therapeutics 278.04 Mn 278.04 Mn - 12.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.99 Mn
Dec 31, 2025 12.81 Mn
Sep 30, 2025 13.71 Mn
Jun 30, 2025 13.81 Mn
Mar 31, 2025 12.36 Mn
Dec 31, 2024 11.07 Mn
Sep 30, 2024 9.94 Mn
Jun 30, 2024 6.58 Mn
Mar 31, 2024 6.37 Mn
Dec 31, 2023 5.79 Mn
Sep 30, 2023 5.45 Mn
Jun 30, 2023 12.15 Mn
Mar 31, 2023 10.57 Mn
Dec 31, 2022 8.46 Mn
Sep 30, 2022 6.16 Mn
Jun 30, 2022 5.10 Mn
Mar 31, 2022 4.20 Mn
Dec 31, 2021 3.45 Mn
Sep 30, 2021 2.78 Mn
Jun 30, 2021 2.38 Mn